Interferon-based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C.

Background: We compared mortality and complications of chronic hepatitis C between treated and untreated Mexican patients after long-term follow-up. We used a time-to-event analysis and identified the prognostic factors.

Material And Methods: Seventy-four patients with chronic hepatitis C were studied.